Feasibility, uptake and impact of a hospital-wide tobacco addiction treatment pathway: Results from the CURE project pilot
| Autor: | Matthew Evison, Michael Rutherford, Richard Booton, David Shackley, Lyn Elsey, Darren Staniforth, Liz Benbow, Kathryn Hoyle, Claire O'Rourke, Mandy Bailey, Helen Huddart, David Regan, Murugesan Raja, Jayne Pilkington, John Britton, Monique Baugh, Julie Jerram, Eileen Ashton, Carol Kearney, Freya Howle, Andrea Crossfield, Richard Preece, Cheryl Pearse |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
medicine.medical_specialty Referral medicine.medical_treatment Population health 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Pharmacotherapy Acute care Tobacco medicine Humans 030212 general & internal medicine Addiction treatment Original Research business.industry Public health Smoking Behavioural intervention General Medicine Hospitals Family medicine Smoking cessation Feasibility Studies Smoking Cessation business |
| Zdroj: | Clinical medicine (London, England). 20(2) |
| ISSN: | 1473-4893 |
| Popis: | Introduction Providing comprehensive tobacco addiction treatment to smokers admitted to acute care settings represents an opportunity to realise major health resource savings and population health improvements. Methods The CURE project is a hospital-wide tobacco addiction treatment service piloted in Wythenshawe Hospital, Manchester, UK. The core components of the project are electronic screening of all patients to identify smokers; the provision of brief advice and pharmacotherapy by frontline staff; opt-out referral of smokers to a specialist team for inpatient behavioural interventions; and continued support after discharge. Results From 01 October 2018 to 31 March 2019, 92% (13,515/14,690) of adult admissions were screened for smoking status, identifying 2,393 current smokers. Of these, 96% were given brief advice to quit by the admitting team. Through the automated ‘opt-out’ referral process, 61% patients completed inpatient behavioural interventions with a specialist cessation practitioner (69% within the first 48 hours of admission). Overall, 66% of smokers were prescribed pharmacotherapy. Over one in five of all smokers admitted during this pilot reported that they were abstinent from smoking 12 weeks after discharge (22%) at a cost £183 per quit. Discussion National implementation of this cost-effective programme would be likely to generate substantial benefits to public health. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|